THERATECHNOLOGIES INC.
29Patents
9Active
29Granted
38Portfolio score
Filing activity: Dec 9, 1993 → Mar 14, 2013 · 5 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5602924A | Electronic stethescope | Human Necessities | 1,004 | Expired |
| US5834418A | Process for the preparation of platelet growth factors extract | Human Necessities | 104 | Expired |
| US6106544A | Cutaneous harness for sutureless wound closing | Human Necessities | 90 | Expired |
| US5843123A | Cutaneous harness for sutureless wound closing | Human Necessities | 54 | Expired |
| US5861379A | Chimeric fatty body-pro-GRF analogs with increased biological potency | Emerging Cross-Sectional Technologies | 22 | Expired |
| US5837204A | System for disinfecting the water lines of a dental unit | Emerging Cross-Sectional Technologies | 21 | Expired |
| US5798523A | Irradiating apparatus using a scanning light source for photodynamic treatment | Human Necessities | 20 | Expired |
| US5939386A | Chimeric fatty body-pro-GRF (1-29) analogs with increased biological potency | Emerging Cross-Sectional Technologies | 20 | Expired |
| US6020311A | GRF analogs with increased biological potency | Human Necessities | 19 | Expired |
| US6458764B1 | GRF analogs with increased biological potency | Emerging Cross-Sectional Technologies | 18 | Expired |
| US7521530B2 | Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor | Human Necessities | 15 | Expired |
| US7316997B2 | GH secretagogues and uses thereof | Chemistry; Metallurgy | 15 | Expired |
| US6194384A | Long-acting galenical formulation for GRF peptides | Human Necessities | 15 | Expired |
| US8435945B2 | GH secretagogues and uses thereof | Chemistry; Metallurgy | 12 | Active |
| US7893025B2 | Use of growth hormone releasing factor analogs in treating patients suffering from wasting | Human Necessities | 12 | Active |
| US8314066B2 | GH secretagogues and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US6864239B2 | Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions | Physics | 9 | Expired |
| US7094761B2 | Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions | Physics | 9 | Expired |
| USD371604S | Sutureless closure for a wound | General | 7 | Expired |
| US7067488B2 | Modified GLP-1 peptides with increased biological potency | Human Necessities | 4 | Expired |
| US8361964B2 | Growth hormone releasing factor (GRF) analogs and uses thereof | Human Necessities | 2 | Active |
| US8481489B2 | GH secretagogues and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US5817627A | Long-acting galenical formulation for GRF peptides | Human Necessities | 1 | Expired |
| US7414029B2 | Antagonistic peptides of prostaglandin E2 receptor subtype EP4 | Emerging Cross-Sectional Technologies | 1 | Expired |
| US9073963B2 | Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.